DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix

NCT00004866 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: exatecan mesylate

Sponsor

Daiichi Sankyo